BriefCase

K221330

Aidoc Medical, Ltd. · cleared 2022-11-18 · product code QAS · Radiology

Premarket evidence — what FDA accepted

Device typesamd
source quote (p.4)
BriefCase is a radiological computer-assisted triage and notification software device.
Algorithmartificial intelligence, deep-learning algorithms
source quote (p.5)
Both devices are artificial intelligence, deep-learning algorithms incorporating software packages for use with DICOM 3.0 compliant x-ray scanners, PACS, and radiology workstations.
Adaptive (vs locked)FDA source did not state this
PCCPFDA source did not state this
Cybersecurity addressedFDA source did not state this

Validation studies (1)

Retrospective clinical

n=921 cases · 5 site(s)

endpoints: sensitivity; specificity; time-to-notification; Positive Predictive Value (PPV); Negative Predictive Value (NPV); Positive Likelihood Ratio (PLR); Negative Likelihood Ratio (NLR)

Reported performance (7 observations)

sensitivity0.8681CI 81.02%-91.36%
source quote (p.9)
Sensitivity was 86.81% (95% CI: 81.02%-91.36%)
specificity0.9202CI 89.20%-93.87%
source quote (p.9)
Specificity was 92.02% (95% CI: 89.20%-93.87%).
npvas written: “NPV at 10% positive prevalence0.9843CI 97.74% - 98.92%
source quote (p.9)
NPV was 98.43% (95% CI: 97.74% - 98.92%), 96.54% (95% CI: 95.05% 97.59%) and 94.21% (95% CI: 91.81% 95.94%) at 10%, 20% and 30% positive prevalence.
ppvas written: “PPV at 10% positive prevalence0.5471CI 48.45% 60.83%
source quote (p.9)
PPV was 54.71% (95% CI: 48.45% 60.83%), 73.11% (95% CI: 67.89%- 77.75%) and 82.33% (95% CI: 78.38%- 85.70%) at 10%, 20% and 30% positive prevalence.
ppvas written: “PLR10.874CI 8.458-13.979
source quote (p.9)
PLR was 10.874 (95% CI: 8.458-13.979)
npvas written: “NLR0.143CI 0.099- 0.208
source quote (p.9)
NLR was 0.143 (95% CI: 0.099- 0.208).
time_to_resultas written: “BriefCase Time-to-notification (Sec)4.93CI 4.64-5.22
source quote (p.9)
BriefCase Time-to-notification 4.93 182 4.64 5.22 4.13 0.76

Each value carries its own analysis unit and task — never compare or pool across devices. Source: 510(k) summary PDF.

Predicate network

Postmarket — what happened after clearance

0
recalls in product code, 24mo
0
MAUDE reports in code, 12mo
vs code's own 3-yr baseline
17
drift signals on this device
  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K253578 (decision 2026-02-26) from Aidoc Medical , Ltd. for a matching device line ("BriefCase-Triage: CARE Multi-Triage CT for Pneumothorax; Pericardial effusion; Large aortic aneurysm; Shoulder fracture or dislocation device") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K253578

  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K251195 (decision 2026-01-27) from Aidoc Medical , Ltd. for a matching device line ("BriefCase-Triage") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K251195

  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K252970 (decision 2026-01-07) from Aidoc Medical , Ltd. for a matching device line ("BriefCase-Triage: CARE Multi-triage CT Body") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K252970

  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K253265 (decision 2025-11-06) from Aidoc Medical , Ltd. for a matching device line ("BriefCase-Triage") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K253265

  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K251406 (decision 2025-05-30) from Aidoc Medical, Ltd. for a matching device line ("BriefCase-Triage") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K251406

  • re_clearance

    The FDA AI/ML device list shows a newer 510(k) K250248 (decision 2025-02-14) from Aidoc Medical, Ltd. for a matching device line ("BriefCase-Triage") — a new clearance for the same line is a change event.

    first seen 2026-07-08 · k_number:K250248

  • …and 11 more.

Recall and MAUDE counts are product-code-level (reports aren't reliably attributable to one device). Signals are descriptive observables with sources — never a judgment that the device is unsafe or drifting. Snapshot 2026-07-08.

Reimbursement — how devices like this got paid

Not yet tracked — no payment pathway indexed for this clearance (the reimbursement corpus is a growing seed set).

RIGOR™ Precedent · public FDA/CMS data · descriptive decision-support, not regulatory or reimbursement advice. Share this page: radar.healthai.com/precedent/device/K221330